Akili Inc. (AKLI)
0.43
-0.00 (-0.46%)
At close: Jul 01, 2024, 8:00 PM
0.43
-0.25%
After-hours: Jul 01, 2024, 04:00 PM EDT
-0.46% (1D)
| Bid | n/a |
| Market Cap | 34.1M |
| Revenue (ttm) | 1.95M |
| Net Income (ttm) | -48.55M |
| EPS (ttm) | -0.61 |
| PE Ratio (ttm) | -0.71 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 236,452 |
| Avg. Volume (20D) | 2,299,004 |
| Open | 0.43 |
| Previous Close | 0.43 |
| Day's Range | 0.43 - 0.43 |
| 52-Week Range | 0.19 - 1.25 |
| Beta | 1.73 |
About AKLI
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts....
Sector Healthcare
IPO Date Jun 30, 2021
Employees 68
Stock Exchange NASDAQ
Ticker Symbol AKLI
Website https://www.akiliinteractive.com